High impact
Panitumumab (Vectibix) (CPB 0748, reviewed 2025-12-23)
Aetna·Effective Dec 23, 2025
CPT 88363, in plain terms, covers Testing archived tissue samples using molecular methods to identify specific genetic or molecular characteristics for diagnostic purposes. CPT 88363 is referenced in 1 tracked payer policy change from Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for CPT 88363 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Official descriptor: CPT 88363 on AAPC
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.